News Source: EurekAlert
"LEHI, UT- A new study published in Nutrition Journal indicates that XanGo® Juice, a market-leading, premium mangosteen beverage, has lowered levels of C-reactive protein (CRP) in overweight and obese people in a randomized, double-blind, placebo-controlled human trial. CRP is a marker used to measure inflammation levels, and a reduction in CRP may indicate a corresponding reduction in the risk of heart disease and diabetes. This study also suggests that XanGo Juice has healthful properties for weight management. Mike Pugh, a scientist at XanGo, explains, "The reason why the scientific community is interested in probing inflammation is that it may be an early indicator of heart attack, stroke and diabetes, potentially even lung disease, skin conditions and arthritis. So, scientists test CRP as a first step in assessing an individual's level of inflammation, and then, in turn, they use that to help picture a patient's potential for these serious diseases." Current understanding of body fat suggests that reducing inflammation may also assist in managing one's weight, which may have wellness benefits of its own.
"
